about
Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patientsParkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorderThe perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effectsMitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutantsWhole genome association studies of neuropsychiatric disease: An emerging era of collaborative genetic discovery.Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson diseaseEffects of gender on nigral gene expression and parkinson disease.Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing miceSignificant linkage of Parkinson disease to chromosome 2q36-37Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease.Parkinsonism and tremor disorders. A clinical approach.Neuropsychology for movement disorders neurosurgery.Genetics of neurological disorders.The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expressionInflammation as a causative factor in the aetiology of Parkinson's diseaseA systematic review of nutritional risk factors of Parkinson's disease.A phenotypic model recapitulating the neuropathology of Parkinson's disease.Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro.Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra.Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function.Familial Parkinson's disease: clinical and genetic analysis of four Basque families.Genetics of Parkinson's disease
P2860
Q24810778-55FBB96E-331A-4825-AEAA-B903C83D056FQ24815148-0BB105DF-E5BA-4E5E-BE57-705C84689778Q28392275-69C4C89B-525A-4B88-8B27-CA2F77437417Q28396222-24FDC9D7-7910-4E76-86ED-137255D985F1Q29615627-29D81CE2-0D4C-4229-BC3A-5BD36693413BQ30440018-3C0C2855-4723-4F4F-955A-D213CD0A3CCBQ30483458-BF4E9C26-5081-45F7-8591-4A65CB5971E8Q33281319-799BDC55-32AA-465F-BFC1-8849AD7A438CQ33315729-BB4F7692-56D7-4DA5-BF7B-774996F0C021Q33680232-BAEEAEF5-711F-442D-B9B8-080E2EF5C003Q33904993-15F5A5FE-EE88-47CF-BD57-929A1A5BA818Q34301507-7634F8DD-F802-47CC-BD3B-659EFC4701CEQ34804035-D2C32FB0-D8D7-4E22-B952-28EF6468201CQ35105765-42270129-B13A-4D6E-B071-9D871B1BA345Q35770559-917927C2-15A4-491C-B3F6-431963BD1C93Q36012226-B10C3F90-FB7B-42C3-B4EE-C7397738D213Q36052641-E92F3DC7-11FA-4D10-936C-86ABA93F71DDQ37350053-6030ED01-DE10-48DA-892F-0049548F552BQ37407288-BEEFA7DE-81F3-4208-A035-19F0AAC0E10AQ40075301-F254BAFF-1ECE-47F4-9E67-8F07AFF13E2BQ42201784-AC03DFBF-CE6B-44AC-BDFB-2102B2ED5257Q44398797-6B6F3875-3828-42F0-A2A0-66A039118D0FQ44686491-AE2E07C9-BC33-4F70-B58E-AA2399A778B2Q49018258-34AF8CAB-88C9-441B-95FA-61DB3B17BA16Q58269122-24EA17F7-4B8B-4A4C-9773-57978085FEF4
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Genetics of parkinsonism.
@ast
Genetics of parkinsonism.
@en
Genetics of parkinsonism.
@nl
type
label
Genetics of parkinsonism.
@ast
Genetics of parkinsonism.
@en
Genetics of parkinsonism.
@nl
prefLabel
Genetics of parkinsonism.
@ast
Genetics of parkinsonism.
@en
Genetics of parkinsonism.
@nl
P2860
P356
P1433
P1476
Genetics of parkinsonism.
@en
P2860
P304
P356
10.1002/MDS.10173
P407
P577
2002-07-01T00:00:00Z